146 related articles for article (PubMed ID: 8059629)
1. Hepatitis caused by low-dose sustained-release niacin.
Schwenk TL; Fisher M
J Am Board Fam Pract; 1994; 7(3):242-4. PubMed ID: 8059629
[No Abstract] [Full Text] [Related]
2. Niacin-induced hepatitis: a potential side effect with low-dose time-release niacin.
Etchason JA; Miller TD; Squires RW; Allison TG; Gau GT; Marttila JK; Kottke BA
Mayo Clin Proc; 1991 Jan; 66(1):23-8. PubMed ID: 1988755
[TBL] [Abstract][Full Text] [Related]
3. Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin.
Henkin Y; Johnson KC; Segrest JP
JAMA; 1990 Jul; 264(2):241-3. PubMed ID: 2355446
[TBL] [Abstract][Full Text] [Related]
4. Hepatotoxicity associated with sustained-release niacin.
Dalton TA; Berry RS
Am J Med; 1992 Jul; 93(1):102-4. PubMed ID: 1626557
[TBL] [Abstract][Full Text] [Related]
5. Acute hepatic failure associated with the use of low-dose sustained-release niacin.
Hodis HN
JAMA; 1990 Jul; 264(2):181. PubMed ID: 2355439
[No Abstract] [Full Text] [Related]
6. Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study.
Rubenfire M;
Am J Cardiol; 2004 Aug; 94(3):306-11. PubMed ID: 15276093
[TBL] [Abstract][Full Text] [Related]
7. Transient focal hepatic defects related to sustained-release niacin.
Lawrence SP
J Clin Gastroenterol; 1993 Apr; 16(3):234-6. PubMed ID: 8505497
[TBL] [Abstract][Full Text] [Related]
8. Rediscovery of crystalline niacin.
Palumbo PJ
Mayo Clin Proc; 1991 Jan; 66(1):112-3. PubMed ID: 1988752
[No Abstract] [Full Text] [Related]
9. Clinical inquiries. Should liver enzymes be checked in a patient taking niacin?
Rizakallah GS; Mertens MK; Brown ML; Sanner L
J Fam Pract; 2005 Mar; 54(3):265-8. PubMed ID: 15755381
[No Abstract] [Full Text] [Related]
10. [Niacin-induced hepatitis].
Tishler M; Abramov AL
Harefuah; 1984 Sep; 107(5-6):129-30. PubMed ID: 6510816
[No Abstract] [Full Text] [Related]
11. Comment: adverse-effect profile of sustained-release niacin.
Jungnickel PW; Maloley PA
DICP; 1991 Sep; 25(9):1014-5. PubMed ID: 1949965
[No Abstract] [Full Text] [Related]
12. Lactic acidosis associated with high-dose niacin therapy.
Earthman TP; Odom L; Mullins CA
South Med J; 1991 Apr; 84(4):496-7. PubMed ID: 2014436
[TBL] [Abstract][Full Text] [Related]
13. Safety and side effects of sustained-release niacin.
Lavie CJ; Milani RV
JAMA; 1994 Aug; 272(7):513-4; author reply 514-5. PubMed ID: 8046796
[No Abstract] [Full Text] [Related]
14. The myth of statin-induced hepatotoxicity.
Bader T
Am J Gastroenterol; 2010 May; 105(5):978-80. PubMed ID: 20445507
[No Abstract] [Full Text] [Related]
15. Niacin: a therapeutic dilemma. "One man's drink is another's poison".
Kreisberg RA
Am J Med; 1994 Oct; 97(4):313-6. PubMed ID: 7942931
[No Abstract] [Full Text] [Related]
16. Adipokines and treatment with niacin.
Westphal S; Borucki K; Taneva E; Makarova R; Luley C
Metabolism; 2006 Oct; 55(10):1283-5. PubMed ID: 16979396
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographic findings in niacin-induced hepatitis.
Scheer MS; Perlmutter S; Ross W; Katz DS
J Ultrasound Med; 1999 Apr; 18(4):321-3. PubMed ID: 10206223
[No Abstract] [Full Text] [Related]
18. Side effects and complications. Extended-release high-dose niacin helps lower lipid levels.
TreatmentUpdate; 2005 Dec; 17(7):7-8. PubMed ID: 17225322
[No Abstract] [Full Text] [Related]
19. Hepatic toxicity of unmodified and time-release preparations of niacin.
Rader JI; Calvert RJ; Hathcock JN
Am J Med; 1992 Jan; 92(1):77-81. PubMed ID: 1731514
[TBL] [Abstract][Full Text] [Related]
20. Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia.
Meyers CD; Carr MC; Park S; Brunzell JD
Ann Intern Med; 2003 Dec; 139(12):996-1002. PubMed ID: 14678919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
